[Form 4] Peraso Inc. Insider Trading Activity

Rhea-AI Filing Summary

Peraso Inc. granted Chief Executive Officer and director Ronald Glibbery a stock option covering 60,000 shares of common stock at an exercise price of $0.87 per share on February 9, 2026.

The option vests in equal monthly installments, with 1/36th of the shares vesting on each monthly anniversary following February 9, 2026, and expires on February 9, 2036. Following this grant, Glibbery beneficially owns 60,000 derivative securities of this option class, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glibbery Ronald

(Last) (First) (Middle)

2033 GATEWAY PLACE

SUITE 500

(Street)

SAN JOSE CA 95110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Peraso Inc. [ PRSO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.87	02/09/2026		A		60,000		(1)	02/09/2036	Common Stock	60,000	$0.00	60,000(2)	D

Explanation of Responses:

1. The option will vest as to 1/36th of the shares subject to the option on each monthly anniversary following February 9, 2026.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan by power of attorney	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Peraso (PRSO) CEO Ronald Glibbery report?

Ronald Glibbery reported receiving a stock option for 60,000 Peraso common shares. The option was granted at a $0.87 exercise price per share and is held directly, representing his total beneficial ownership of this option class after the transaction.

What are the key terms of Ronald Glibbery’s 60,000 Peraso stock options?

The option covers 60,000 Peraso common shares at a $0.87 exercise price. It was granted on February 9, 2026, and expires on February 9, 2036, giving a 10-year term for potential exercise under the specified vesting schedule.

How do Ronald Glibbery’s Peraso stock options vest over time?

The 60,000-share option vests gradually, with 1/36th of the shares vesting on each monthly anniversary after February 9, 2026. This structure creates three years of monthly vesting, aligning ongoing equity compensation with continued service at Peraso.

How many Peraso derivative securities does Ronald Glibbery own after this grant?

After this option grant, Ronald Glibbery beneficially owns 60,000 derivative securities of the reported option class. The filing clarifies that this total applies only to options with the same terms, excluding other options with different prices or vesting.

What is the significance of the $0.00 price reported for Ronald Glibbery’s option grant?

The $0.00 price indicates Glibbery paid no cash to receive the 60,000-share option grant. Instead, the economic cost is embedded in the $0.87 per share exercise price, which must be paid if and when he chooses to exercise vested options.